Skip to main content

Main menu

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
  • AAPL

User menu

  • Alerts

Search

  • Advanced search
Journal of the American Academy of Psychiatry and the Law
  • AAPL
  • Alerts
Journal of the American Academy of Psychiatry and the Law

Advanced Search

  • Home
  • Current Issue
  • Ahead of Print
  • Past Issues
  • Info for
    • Authors
    • Print Subscriptions
  • About
    • About the Journal
    • About the Academy
    • Editorial Board
  • Feedback
  • Alerts
EditorialEDITORIAL

Regulating Ketamine Use in Psychiatry

Lisa Harding
Journal of the American Academy of Psychiatry and the Law Online September 2023, 51 (3) 320-325; DOI: https://doi.org/10.29158/JAAPL.230040-23
Lisa Harding
Dr. Harding is a psychiatrist in independent practice in Connecticut and is Assistant Clinical Professor of Psychiatry, Yale University School of Medicine, New Haven, CT.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    Dependence Potential of Psychoactive Drug. (Generated from Data Presented in Gable34)

    Dependence potentialPsychoactive substance(s)
    Very Highheroin
    Highnicotine, morphine
    Moderate Highcocaine, pentobarbital
    Moderatealcohol, ephedra, flunitrazepam
    Moderate Lowcaffeine, marijuana, MDMA, nitrous oxide
    Lowketamine
    Very LowLSD, mescaline, psilocybin
PreviousNext
Back to top

In this issue

Journal of the American Academy of Psychiatry and the Law Online: 51 (3)
Journal of the American Academy of Psychiatry and the Law Online
Vol. 51, Issue 3
1 Sep 2023
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in recommending The Journal of the American Academy of Psychiatry and the Law site.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Regulating Ketamine Use in Psychiatry
(Your Name) has forwarded a page to you from Journal of the American Academy of Psychiatry and the Law
(Your Name) thought you would like to see this page from the Journal of the American Academy of Psychiatry and the Law web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Regulating Ketamine Use in Psychiatry
Lisa Harding
Journal of the American Academy of Psychiatry and the Law Online Sep 2023, 51 (3) 320-325; DOI: 10.29158/JAAPL.230040-23

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Regulating Ketamine Use in Psychiatry
Lisa Harding
Journal of the American Academy of Psychiatry and the Law Online Sep 2023, 51 (3) 320-325; DOI: 10.29158/JAAPL.230040-23
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical Trials and Evidence-Based Use
    • Licensing and Prescribing
    • Risk Management and Monitoring
    • Patient Access and Affordability
    • Esketamine and Ketamine in Corrections
    • Ketamine and the Legal Landscape
    • Stigma and Media
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Challenges and Opportunities for Forensic Mental Health in Immigration Courts
  • State Hospital Rotations Allow Residents to Regain the Longitudinal Experiences of Yesteryear
  • Medical Misogyny and the Implications of Not Believing Women
Show more Editorial

Similar Articles

Keywords

  • esketamine
  • ketamine
  • regulation

Site Navigation

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Information for Authors
  • About the Journal
  • Editorial Board
  • Feedback
  • Alerts

Other Resources

  • Academy Website
  • AAPL Meetings
  • AAPL Annual Review Course

Reviewers

  • Peer Reviewers

Other Publications

  • AAPL Practice Guidelines
  • AAPL Newsletter
  • AAPL Ethics Guidelines
  • AAPL Amicus Briefs
  • Landmark Cases

Customer Service

  • Cookie Policy
  • Reprints and Permissions
  • Order Physical Copy

Copyright © 2025 by The American Academy of Psychiatry and the Law